USP Zdrowie has finalized the transaction of purchasing the Multilac brand and its subsidiaries and rights from Genexo Sp. z o.o.

Multilac has been on the Polish market for 10 years and is the quantitative leader in the probiotic market in Poland, effectively competing with brands such as Dicoflor and Acidolac.

The acquisition of this brand perfectly complements the product portfolio of USP Zdrowie and is a significant element in the implementation of the ambitious long-term growth strategy.